PM Modi suggests developing Covid-19 vaccine delivery plan for speedy access to citizens | WeForNews | Latest News, Blogs PM Modi suggests developing Covid-19 vaccine delivery plan for speedy access to citizens – WeForNews | Latest News, Blogs
Connect with us

Health

PM Modi suggests developing Covid-19 vaccine delivery plan for speedy access to citizens

According to a statement by the government, the Prime Minister’s Office (PMO) also said that three vaccines are in advanced stages of development in India, out of which two are in Phase II and one is in Phase-III.

Published

on

Narendra Modi

Prime Minister Narendra Modi Saturday chaired a meeting to review the ongoing Covid-19 pandemic situation in the country and suggested developing a vaccine delivery system on the lines of conduct of polls and disaster management while involving all levels of government and citizen groups. He also called for full preparedness to ensure speedy access to COVID-19 vaccines for every citizen.

In a statement, the Prime Minister’s Office (PMO) also said that three vaccines are in advanced stages of development in India, out of which two are in Phase II and one is in Phase-III. The statement added that Indian scientists and research teams are collaborating and strengthening the research capacities in neighbouring countries such as Afghanistan, Bhutan, Bangladesh, Maldives, Mauritius, Nepal and Sri Lanka.

The review meeting today was attended by Union Health Minister Harsh Vardhan, Principal Secretary to PM, Member (Health) NITI Aayog, Principal Scientific Advisor, senior scientists, officers of PMO, and officials from various other departments.

National Expert Group on Vaccine Administration for COVID-19 (NEGVAC) in consultation with state governments and all relevant stakeholders have prepared and presented a detailed blueprint of vaccine storage, distribution, and administration, the government said.

It further said two pan-India studies on the Genome of SARS-CoV-2 (COVID-19 virus) in India conducted by ICMR and Department of BioTechnology (DBT) suggest that the virus is genetically stable and there is no major mutation in the virus.

India’s COVID-19 caseload has gone past 74 lakh, while the number of people who have recuperated from the disease has crossed 65 lakh pushing the recovery rate to 87.78 per cent, according to data updated by the Union Health Ministry on Saturday.

Health

Researchers identify new drug to treat COVID-19 patients

In the continuing fight against the novel Coronavirus, researchers have now identified a drug with the potential to provide treatment for COVID-19 close to a year after it turned into a pandemic

Published

on

By

Coronavirus News

In the continuing fight against the novel Coronavirus, researchers have now identified a drug with the potential to provide treatment for COVID-19 close to a year after it turned into a pandemic.

The study, published in the journal Cells, found that the approved protease inhibitor aprotinin displayed activity against SARS-CoV-2, the coronavirus that causes COVID-19, in concentrations that are achieved in patients.

According to the researchers, aprotinin aerosols are approved in Russia for the treatment of influenza and could be readily tested for the treatment of COVID-19.

Aprotinin inhibits the entry of SARS-CoV-2 into host cells and may compensate for the loss of host cell protease inhibitors that are downregulated upon SARS-CoV-2 infection.

“The aprotinin aerosol has been reported to be tolerated extremely well in influenza patients. Hence, it may have a particular potential to prevent severe COVID-19 disease when applied early after diagnosis,” said study author Martin Michaelis from the University of Kent in the UK.

“Aprotinin has previously been shown to inhibit TMPRSS2 gene and has been suggested as a treatment option for influenza viruses and coronaviruses. Herein, we investigated the effects of aprotinin against SARS-CoV-2,” Michaelis added.

The findings showed that aprotinin displayed anti-SARS-CoV-2 activity in different cell types (Caco2, Calu-3, and primary bronchial epithelial cell air-liquid interface cultures) and against four virus isolates.

“An approved aprotinin aerosol may have the potential for the early local control of SARS-CoV-2 replication and the prevention of COVID-19 progression to a severe, systemic disease,” the study authors noted.

Continue Reading

Health

No dengue death in Delhi this year

Delhi govt announced zero death in the national capital due to dengue this year so far, giving credit to CM Kejriwal’s campaign against the mosquito-borne tropical disease caused by the dengue virus

Published

on

By

Arvind Kejriwal

Delhi government on Saturday announced zero death in the national capital due to dengue this year so far, giving credit to Chief Minister Arvind Kejriwal’s campaign against the mosquito-borne tropical disease caused by the dengue virus.

The announcement comes as it is going to organise the ninth week of ’10 Hafte 10 Baje, 10 Minute’ anti-dengue campaign on Sunday with Delhi Chief Minister Arvind Kejriwal appealing the citizen to join the movement.

“This is the second last week of the campaign and due to the aggressive campaign by the Delhi government this year no dengue-related death has been reported in the national capital,” the government said in a statement.

This week Delhi Health Minister Satyendar Jain also informed that no dengue-related death has been reported in the national capital this year and credited Kejriwal government’s anti-dengue campaign for this.

“Delhi people did it! No death due to dengue this year. There is also a sharp fall in number of cases compared to figures reported last year. Chief Minister Arvind Kejriwal’s campaign — ’10 hafte 10 baje 10 minute’ — has been made a success by you all,” Jain had tweeted.

As per the Delhi government statement, the Delhi model of fighting dengue is getting applauded across the country and Bollywood actor Amitabh Bachchan recently asked a question about the campaign to a contestant by playing a voice clip of the Delhi Chief Minister in the popular television show KBC.

Delhi Chief Minister Kejriwal earlier had urged citizens here for their collective efforts against the disease, saying “we have to stop the breeding of dengue mosquitoes and protect our family and the entire Delhi from Dengue.”

Kejriwal on last Sunday had also declared that dengue was “under control” in the national capital like previous year.

Last week, the anti-dengue campaign of the Delhi government got support from celebrities such as Shankar Mahadevan, who encouraged the citizens of Delhi to religiously follow the dengue prevention guidelines such as inspecting their residences for signs of stagnant water, draining the accumulated water or adding a layer of oil or petrol to it to prevent the breeding of mosquitoes.

The Delhi government this year launched a Dengue helpline — 01123300012 — and a WhatsApp helpline — 8595920530 — to assist the general public.

Continue Reading

Health

Sero Survey In Bhubaneswar: 50% Residents Develop Antibodies To Fight Coronavirus

Published

on

By

Coronavirus outbreak

Bhubaneswar: Half of the residents of Bhubaneswar have developed antibodies to fight novel Coronavirus. The statistics were revealed by ICMR – Regional Medical Research Centre (RMRC) Director, Dr Sanghamitra Pati today. Dr Pati said the survey was carried out between October 16 and 18 during which 1,400 samples were taken from all wards of Bhubaneswar Municipal Corporation (BMC).

As per the results, 50 per cent of Bhubaneswar’s population have been exposed to COVID-19, which means these many number of people now have the antibodies against the viral disease. “The results of the third sero survey corresponds to the status of infection, at least three weeks prior. So, there is much likelihood that exposure of people here to COVID-19 would have increased by now (October-end),” she said.

The good news is that 90 per cent of the people who are exposed to COVID-19 have very less or no symptoms. This implies that their immune system has been successful in fighting novel Coronavirus. Besides, 30 per cent of the people whose samples were collected have been tested through Rapid Antigen or RT-PCR, said Dr Pati.

Only around 2 per cent of Bhubaneswar’s population was found to be exposed to COVID-19 in the first sero survey. In the second survey in the last week of August, 5.1 per cent of the city’s population was exposed. Now, the result of the third sero survey is very encouraging, she said.

Continue Reading
Advertisement

Most Popular

Corona Virus (COVID-19) Live Data

COVID-19 affects different people in different ways. Most infected people will develop mild to moderate illness and recover without hospitalization.